“…While traditionally believed that the hypersensitivity to gluten peptides is limited to the small intestine in patients with CeD, it is now known that CeD affects many other organs, including skin, liver, kidney, bone, and brain, and hence, CeD is now considered to be a systemic disorder altogether. [23][24][25][26] While symptoms of CeD were typically defined as those related to malabsorption, such as chronic diarrhea, steatorrhea, weight loss, failure-to-thrive in children, short stature, irritability, excessive flatulence, and recurrent aphthous ulcers (classical CeD), [27][28][29] it is increasingly being recognized that the patients can have extraintestinal manifestations in the absence of or minimal gastrointestinal symptoms such as short stature, ataxia, hypertransaminasemia, cirrhosis of liver, and osteomalacia (atypical CeD). 30 Education and increased awareness of medical communities across specialties, as well as during initial years of training, is thus needed to allow for a timely diagnosis of CeD and institution of early intervention, which will prevent organ damage.…”